Your browser doesn't support javascript.
loading
HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
Lyons, Danielle E; Kumar, Priti; Roan, Nadia R; Defechereux, Patricia A; Feschotte, Cedric; Lange, Ulrike C; Murthy, Niren; Sameshima, Pauline; Verdin, Eric; Ake, Julie A; Parsons, Matthew S; Nath, Avindra; Gianella, Sara; Smith, Davey M; Kallas, Esper G; Villa, Thomas J; Strange, Richard; Mwesigwa, Betty; Furler O'Brien, Robert L; Nixon, Douglas F; Ndhlovu, Lishomwa C; Valente, Susana T; Ott, Melanie.
Afiliação
  • Lyons DE; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158, USA.
  • Kumar P; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA.
  • Roan NR; Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158, USA.
  • Defechereux PA; Department of Urology, University of California San Francisco, San Francisco, CA 94158, USA.
  • Feschotte C; Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
  • Lange UC; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
  • Murthy N; Leibniz Institute of Virology, 20251 Hamburg, Germany.
  • Sameshima P; Department of Bioengineering, University of California, Berkeley, CA 94720, USA.
  • Verdin E; Innovative Genomics Institute, Berkeley, CA 94720, USA.
  • Ake JA; Faculty of Education, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
  • Parsons MS; Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
  • Nath A; Buck Institute for Research on Aging, Novato, CA 94945, USA.
  • Gianella S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
  • Smith DM; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
  • Kallas EG; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.
  • Villa TJ; Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.
  • Strange R; Section of Infections of the Nervous System, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20824, USA.
  • Mwesigwa B; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, CA 92093, USA.
  • Furler O'Brien RL; Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, CA 92093, USA.
  • Nixon DF; Department of Infectious and Parasitic Diseases, University of Sao Paulo, São Paulo 04023-900, Brazil.
  • Ndhlovu LC; HOPE Martin Delaney Collaboratory for HIV Cure Research Community Engagement Ambassador, Washinton, DC 20004, USA.
  • Valente ST; National HIV & Aging Advocacy Network, Washington, DC 20004, USA.
  • Ott M; HOPE Martin Delaney Collaboratory for HIV Cure Research Community Engagement Ambassador, Washinton, DC 20004, USA.
Viruses ; 15(11)2023 Oct 28.
Article em En | MEDLINE | ID: mdl-38005849
ABSTRACT
Despite remarkable progress, a cure for HIV-1 infection remains elusive. Rebound competent latent and transcriptionally active reservoir cells persevere despite antiretroviral therapy and rekindle infection due to inefficient proviral silencing. We propose a novel "block-lock-stop" approach, entailing long term durable silencing of viral expression towards an irreversible transcriptionally inactive latent provirus to achieve long term antiretroviral free control of the virus. A graded transformation of remnant HIV-1 in PLWH from persistent into silent to permanently defective proviruses is proposed, emulating and accelerating the natural path that human endogenous retroviruses (HERVs) take over millions of years. This hypothesis was based on research into delineating the mechanisms of HIV-1 latency, lessons from latency reversing agents and advances of Tat inhibitors, as well as expertise in the biology of HERVs. Insights from elite controllers and the availability of advanced genome engineering technologies for the direct excision of remnant virus set the stage for a rapid path to an HIV-1 cure.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Retrovirus Endógenos Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Retrovirus Endógenos Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos